A better understanding of the disease pathogenesis of mantle cell lymphoma and the availability of better therapies means people with mantle cell lymphoma are living longer. Chair of the Lymphoma group at Weill Cornell Medicine in New York Associate Professor Peter Martin gives advice to local haematologists on how to optimise outcomes for their MCL ...
How to optimise therapy in mantle cell lymphoma
23 Aug 2018
Sponsored by Janssen-Cilag Pty Ltd